EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?

Munique Kurtz De Mello, Natália Sousa Freitas Queiroz, Konstantinos Papamichael

Clinical Gastroenterology and Hepatology · 2024

DOI: 10.1016/j.cgh.2023.05.007 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von Munique Kurtz De Mello und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Vale do Itajaí, Itajaí, Brazil. Hauptthemen laut MEDLINE: Drug Monitoring, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringInflammatory Bowel DiseasesHumansPharmacogeneticsTumor Necrosis Factor-alphaNecrosisGastrointestinal AgentsInfliximab

Substanzen

Tumor Necrosis Factor-alphaGastrointestinal AgentsInfliximab

Autor:innen und Institutionen

  • University of Vale do Itajaí, Itajaí, Brazil.
  • Division of Gastroenterology, Pontifical Catholic University of Paraná (PUCPR), Curitiba, Brazil; Santa Cruz Hospital, Curitiba, Brazil.
  • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

De Mello, M. K., Freitas Queiroz, N. S., & Papamichael, K. (2024). Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.05.007

Vancouver

De Mello MK, Freitas Queiroz NS, Papamichael K. Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2023.05.007

BibTeX
@article{DeMello2024,
  author = {De Mello, Munique Kurtz and Freitas Queiroz, Natália Sousa and Papamichael, Konstantinos},
  title = {Can Proactive Therapeutic Drug Monitoring Overcome Pharmacogenomic-Associated Immunogenicity to Anti-Tumor Necrosis Factor Agents?},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1016/j.cgh.2023.05.007}
}
Kostenlos starten →